Federal health officials are pushing forward with a plan to open up access to injectable peptides, a drug class that remains unproven.
Recap by typeshit. Full story at The Seattle Times.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Shea's team is joining a protein design competition aimed at building a new protein that switches on the same receptor Ozempic targets.
Among adults who were drinking when they started a GLP-1 receptor agonist, close to half said their alcohol use went down, JAMA Psychiatry reports.
Loading…